AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
Plus Therapeutics (PSTV) announces three positive clinical data update presentations at the World Federation of Neuro-Oncology Societies/Society ...
Plus Therapeutics Inc. (NASDAQ:PSTV) jumped 60% in premarket trading Thursday following news of a national agreement with UnitedHealthcare Insurance Company (NYSE:UNH) covering its CNSide® ...
The US Pharmacopeia (USP), the Japanese Pharmacopoeia, and the European Pharmacopoeia "Microbial Limits Tests" are in the final stages of harmonization. The harmonized USP chapters are slated for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback